These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9222424)
1. Complement resistance of Leishmania amazonensis promastigotes is independent of parasite proteases and lysis of sensitive forms is not due to natural antibodies in normal human serum. Nunes AC; Ramalho-Pinto FJ Braz J Med Biol Res; 1996 Dec; 29(12):1633-40. PubMed ID: 9222424 [TBL] [Abstract][Full Text] [Related]
2. Leishmania amazonensis promastigotes evade complement killing by interfering with the late steps of the cascade. Nunes AC; Almeida-Campos FR; Horta MF; Ramalho-Pinto FJ Parasitology; 1997 Dec; 115 ( Pt 6)():601-9. PubMed ID: 9488871 [TBL] [Abstract][Full Text] [Related]
3. Leishmania species: mechanisms of complement activation by five strains of promastigotes. Mosser DM; Burke SK; Coutavas EE; Wedgwood JF; Edelson PJ Exp Parasitol; 1986 Dec; 62(3):394-404. PubMed ID: 3780933 [TBL] [Abstract][Full Text] [Related]
4. Acid protease activity of a major surface membrane glycoprotein (gp63) from Leishmania mexicana promastigotes. Chaudhuri G; Chang KP Mol Biochem Parasitol; 1988 Jan; 27(1):43-52. PubMed ID: 3278222 [TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of New World Leishmania spp. promastigotes to complement-mediated lysis: correlation with the expression of three parasite polypeptides. Noronha FS; Nunes AC; Souza KT; Melo MN; Ramalho-Pinto FJ Acta Trop; 1998 Mar; 69(1):17-29. PubMed ID: 9588238 [TBL] [Abstract][Full Text] [Related]
7. Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3. Mosser DM; Wedgwood JF; Edelson PJ J Immunol; 1985 Jun; 134(6):4128-31. PubMed ID: 3886796 [TBL] [Abstract][Full Text] [Related]
8. Destruction of Leishmania mexicana amazonensis promastigotes by normal human serum. Barral-Netto M; Roters SB; Sherlock I; Reed SG Am J Trop Med Hyg; 1987 Jul; 37(1):53-6. PubMed ID: 3605505 [TBL] [Abstract][Full Text] [Related]
9. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa. Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449 [TBL] [Abstract][Full Text] [Related]
10. Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes. Silva-Lopez RE; Morgado-Díaz JA; Chávez MA; Giovanni-De-Simone S Parasitol Res; 2007 Nov; 101(6):1627-35. PubMed ID: 17726617 [TBL] [Abstract][Full Text] [Related]
11. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. Mosser DM; Edelson PJ J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545 [TBL] [Abstract][Full Text] [Related]
12. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. Russell DG Eur J Biochem; 1987 Apr; 164(1):213-21. PubMed ID: 3549304 [TBL] [Abstract][Full Text] [Related]
13. Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Seay MB; Heard PL; Chaudhuri G Infect Immun; 1996 Dec; 64(12):5129-37. PubMed ID: 8945556 [TBL] [Abstract][Full Text] [Related]
14. Leishmania (Leishmania) amazonensis: differential expression of proteinases and cell-surface polypeptides in avirulent and virulent promastigotes. de Araújo Soares RM; dos Santos AL; Bonaldo MC; de Andrade AF; Alviano CS; Angluster J; Goldenberg S Exp Parasitol; 2003; 104(3-4):104-12. PubMed ID: 14552857 [TBL] [Abstract][Full Text] [Related]
15. Leishmania amazonensis: long-term cultivation of axenic amastigotes is associated to metacyclogenesis of promastigotes. Cysne-Finkelstein L; Temporal RM; Alves FA; Leon LL Exp Parasitol; 1998 May; 89(1):58-62. PubMed ID: 9603489 [TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of an intracellular serine protease of 68 kDa in Leishmania (Leishmania) amazonensis promastigotes. Morgado-Díaz JA; Silva-Lopez RE; Alves CR; Soares MJ; Corte-Real S; De Simone SG Mem Inst Oswaldo Cruz; 2005 Jul; 100(4):377-83. PubMed ID: 16113885 [TBL] [Abstract][Full Text] [Related]
17. Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes. Ramer-Tait AE; Lei SM; Bellaire BH; Beetham JK J Parasitol; 2012 Dec; 98(6):1109-16. PubMed ID: 22662870 [TBL] [Abstract][Full Text] [Related]
18. Metacyclogenesis of Leishmania spp: species-specific in vitro transformation, complement resistance, and cell surface carbohydrate and protein profiles. Bandyopadhyay P; Ghosh DK; De A; Ghosh KN; Chaudhuri PP; Das P; Bhattacharya A J Parasitol; 1991 Jun; 77(3):411-6. PubMed ID: 2040953 [TBL] [Abstract][Full Text] [Related]
19. In vitro metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis clinical field isolates, as evaluated by morphology, complement resistance, and infectivity to human macrophages. da Silva IA; Morato CI; Quixabeira VB; Pereira LI; Dorta ML; de Oliveira MA; Horta MF; Ribeiro-Dias F Biomed Res Int; 2015; 2015():393049. PubMed ID: 25695070 [TBL] [Abstract][Full Text] [Related]
20. Phosphomonoesterases of Leishmania mexicana mexicana and other flagellates. Hassan HF; Coombs GH Mol Biochem Parasitol; 1987 Apr; 23(3):285-96. PubMed ID: 3037369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]